Core Viewpoint - DBS has raised the target price for Manulife Financial-S (00945) from HKD 290 to HKD 310 while maintaining a "Buy" rating, indicating confidence in the stock's potential for valuation re-rating [1] Group 1: Financial Performance - Manulife Financial reported better-than-expected performance for Q3 2025, with new business value increasing by 11% year-on-year, and a 7% growth in the Asia region [2] - The growth in new business value is attributed to a shift in the product mix towards high-margin health insurance products, particularly in the Asian and US markets, which has effectively improved profit margins [2] - New business contract service margins saw a significant year-on-year increase of 25%, with a 20% increase in the Asia region, driven by product mix optimization and positive impacts from recent actuarial assessments [2] Group 2: Strategic Initiatives - Manulife's innovation strategy focuses on growth, emphasizing strong growth potential in wealth and asset management businesses in Asia and globally [1] - The company is expanding its operations in Canada and the US to maintain a diversified and balanced global investment portfolio [1] - A joint venture with Mahindra to enter the Indian insurance market is expected to create new growth opportunities, leveraging Mahindra's strong brand and execution track record [2] - The timing of the entry into the Indian market is strategic, given the improving digital infrastructure and favorable regulatory environment for foreign insurance companies [2]

Core Viewpoint - DBS has raised the target price for Manulife Financial (00945) from HKD 290 to HKD 310 while maintaining a "Buy" rating, indicating confidence in the stock's potential for continued valuation re-rating [1] Group 1: Financial Performance - Manulife Financial reported better-than-expected performance in Q3 2025, with new business value increasing by 11% year-on-year, and a 7% growth in the Asia region [2] - The growth is attributed to a shift in the product mix towards higher-margin health insurance products, particularly in the Asian and US markets, which has effectively improved profit margins and driven business growth [2] - New business contract service margins saw a significant year-on-year increase of 25%, with Asia's new business contract service margins also recording a 20% year-on-year growth [2] Group 2: Strategic Initiatives - Manulife's innovation strategy focuses on growth, emphasizing strong growth potential in both Asian and global wealth and asset management businesses [1] - The company is expanding its operations in Canada and the US to maintain a diversified and balanced global investment portfolio [1] - A joint venture with Mahindra to enter the Indian insurance market is expected to add growth opportunities, leveraging Mahindra's strong brand and execution track record [2] - The timing of the entry into the Indian market is strategic, given the improving digital infrastructure and favorable regulatory environment for foreign insurance companies [2]

Core Viewpoint - Manulife Financial's growth-focused innovation strategy emphasizes strong growth potential in its wealth and asset management business in Asia and globally [1] Group 1: Strategic Focus - The company aims to expand its business in Canada and the United States to maintain a diversified and balanced global investment portfolio [1] - Manulife is transitioning to an AI-driven organization with large-scale applications [1] - The company plans to enhance customer health, wealth, and longevity protection through value-added solutions and services [1] Group 2: Financial Outlook - The strategic enhancements are expected to help the company achieve its financial targets for 2027 and strengthen its sustainable long-term growth trajectory [1] - DBS has raised Manulife's target price from HKD 290 to HKD 310 and maintains a "Buy" rating [1]

Core Insights - The article provides a comparative analysis of Manulife Financial, focusing on its growth in Asia and improving earnings mix compared to its closest competitors [1]. Group 1: Company Overview - Manulife Financial is highlighted for its growth potential in the Asian market, which is a significant aspect of its overall strategy [1]. - The company is noted for its improving earnings mix, indicating a shift towards more profitable segments [1]. Group 2: Analyst Perspective - The insights presented in the article are based on the author's independent research and do not reflect any external financial interests [2]. - The article emphasizes that past performance is not indicative of future results, underscoring the importance of careful investment consideration [3].

Core Insights - The article provides a comparative analysis of Manulife Financial, focusing on its growth in Asia and improving earnings mix compared to its closest competitors [1]. Group 1: Company Overview - Manulife Financial is highlighted for its growth potential in the Asian market, which is a significant aspect of its business strategy [1]. - The company is noted for its improving earnings mix, indicating a shift towards more profitable segments [1]. Group 2: Analyst Perspective - The insights presented in the article are based on the author's independent research and do not reflect any financial interests or relationships with the companies mentioned [2]. - The article emphasizes that past performance is not indicative of future results, underscoring the importance of careful investment consideration [3].

Core Viewpoint - Manulife Investments announced the final cash distributions for its ETFs and ETF series of mutual funds for December 2025, with payments scheduled for January 15, 2026 [1]. Distribution Details - The cash distribution amounts per unit for various Manulife ETFs are as follows: - Manulife Smart Short-Term Bond ETF (TERM): C$0.025324, Monthly - Manulife Smart Core Bond ETF (BSKT): C$0.022317, Monthly - Manulife Smart Corporate Bond ETF (CBND): C$0.027779, Monthly - Manulife Smart Global Bond ETF (GBND): C$0.022743, Monthly - Manulife Smart Enhanced Yield ETF (CYLD): C$0.160000, Monthly - Manulife Smart U.S. Enhanced Yield ETF – Unhedged (UYLD.B): C$0.160000, Monthly - Manulife Smart U.S. Enhanced Yield ETF – US Dollar (UYLD.U): C$0.160000*, Monthly - Manulife Smart U.S. Enhanced Yield ETF – Hedged (UYLD): C$0.160000, Monthly - Manulife Smart Enhanced Yield Bond ETF– Unhedged (BYLD.B): C$0.116674, Monthly - Manulife Smart Enhanced Yield Bond ETF – Hedged (BYLD): C$0.115931, Monthly - Manulife Global Edge ETF (GEDG): C$0.001234, Quarterly - Manulife Smart Dividend ETF (CDIV): C$0.132244, Quarterly - Manulife Smart U.S. Dividend ETF – Unhedged (UDIV.B): C$0.102016, Quarterly - Manulife Smart U.S. Dividend ETF – Hedged (UDIV): C$0.094651, Quarterly - Manulife Smart U.S. Dividend ETF – US Dollar (UDIV.U): C$0.076214*, Quarterly - Manulife Smart International Dividend ETF – Unhedged (IDIV.B): C$0.111599, Quarterly - Manulife Smart Global Dividend ETF Portfolio (GDIV): C$0.093047, Quarterly - Manulife Smart Defensive Equity ETF (CDEF): C$0.202209, Semi-Annual - Manulife Smart U.S. Defensive Equity ETF – Unhedged (UDEF.B): C$0.078236, Semi-Annual - Manulife Smart U.S. Defensive Equity ETF – Hedged (UDEF): C$0.063902, Semi-Annual - Manulife Smart U.S. Defensive Equity ETF – US Dollar (UDEF.U): C$0.083723*, Semi-Annual - Manulife Smart International Defensive Equity ETF – Unhedged (IDEF.B): C$0.175154, Semi-Annual - Manulife Multifactor Canadian Large Cap Index ETF (MCLC): C$0.500360, Semi-Annual - Manulife Multifactor U.S. Large Cap Index ETF – Unhedged (MULC.B): C$0.347524, Semi-Annual - Manulife Multifactor U.S. Large Cap Index ETF – Hedged (MULC): C$0.266310, Semi-Annual - Manulife Multifactor U.S. Mid Cap Index ETF – Unhedged (MUMC.B): C$0.282933, Semi-Annual - Manulife Multifactor U.S. Mid Cap Index ETF – Hedged (MUMC): C$0.250437, Semi-Annual - Manulife Multifactor Developed International Index ETF – Unhedged (MINT.B): C$0.917531, Semi-Annual - Manulife Multifactor Developed International Index ETF – Hedged (MINT): C$0.742856, Semi-Annual - Manulife Multifactor Canadian SMID Cap Index ETF (MCSM): C$0.426010, Semi-Annual - Manulife Multifactor U.S. Small Cap Index ETF – Unhedged (MUSC.B): C$0.164171, Semi-Annual - Manulife Multifactor U.S. Small Cap Index ETF – Hedged (MUSC): C$0.139439, Semi-Annual - Manulife Multifactor Emerging Markets Index ETF – Unhedged (MEME.B): C$0.415626, Semi-Annual - Manulife Strategic Income Fund – ETF Series (STRT): C$0.030746, Monthly - Manulife Core Plus Bond Fund – ETF Series (MCOR): C$0.032697, Monthly - Manulife Dividend Income Fund – ETF Series (MDIF): C$0.012902, Monthly - Manulife Alternative Opportunities Fund – ETF Series (OPPS): C$0.034416, Monthly - Manulife Strategic Income Plus Fund – ETF Series (PLUS): C$0.039899, Monthly - Manulife Fundamental Equity Fund – ETF Series (MFUN): C$0.025530, Quarterly [1]. Company Overview - Manulife Financial Corporation is a leading international financial services provider, operating globally under the Manulife brand in Canada, Asia, and Europe, and as John Hancock in the United States [6]. - The company provides financial advice, insurance, and investment services to over 36 million customers, supported by more than 37,000 employees and over 109,000 agents [6].

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, with the aim of buying high and selling higher, capitalizing on established price movements [1] Company Overview: Manulife Financial (MFC) - Manulife Financial currently holds a Momentum Style Score of B, indicating potential as a solid momentum pick [3][12] - The company has a Zacks Rank of 2 (Buy), which is associated with strong historical performance [4] Performance Metrics - Over the past week, MFC shares increased by 1.92%, matching the performance of the Zacks Insurance - Life Insurance industry [6] - In the last month, MFC's price rose by 4.76%, while the industry saw a 6.39% increase [6] - Over the past quarter, MFC shares have risen by 17.84%, and by 19.26% over the last year, significantly outperforming the S&P 500, which increased by 3.01% and 17.28% respectively [7] Trading Volume - MFC's average 20-day trading volume is 2,485,539 shares, which serves as a bullish indicator when combined with rising stock prices [8] Earnings Outlook - In the past two months, two earnings estimates for MFC have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $2.87 to $2.95 [10] - For the next fiscal year, two estimates have also moved upwards without any downward revisions [10]

Key Points - As of December 19, 38 stocks reached their 52-week highs, with Li Gao Health Life (02370), Ginkgo Education (01851), and Kangqiao Yuelife (02205) leading the high rate at 36.36%, 18.72%, and 8.70% respectively [1] - The top three stocks that achieved new highs are as follows: - Li Gao Health Life (02370) closed at 0.670, with a peak of 0.750, marking a 36.36% increase - Ginkgo Education (01851) closed at 2.430, with a peak of 2.600, marking an 18.72% increase - Kangqiao Yuelife (02205) closed at 1.200, with a peak of 1.250, marking an 8.70% increase [1] - Other notable stocks that reached new highs include Liangqing Holdings (1,000) at 7.14%, Jinxing International Holdings (02307) at 7.04%, and Wuxi Life (08148) at 6.21% [1] 52-Week Low Summary - The 52-week low rankings show that Haowen Holdings (08019) had the largest decline at -16.13%, closing at 0.130 [2] - Other significant declines include NIU Holdings (08619) at -11.86%, closing at 0.156, and Hashkey HLDGS (03887) at -9.59%, with a low of 5.090 [2] - Additional stocks with notable declines include Songdu Service (09608) at -9.09%, closing at 0.068, and Ruike Bio-B (02179) at -5.41%, closing at 5.070 [2]

Core Insights - Manulife Financial Corporation reported third-quarter 2025 core earnings of 84 cents per share, exceeding the Zacks Consensus Estimate by 13.5% and reflecting a 15% year-over-year improvement [2][3] - The company's core earnings totaled $1.4 billion (C$2 billion), marking a 7.6% increase year over year, driven by strong growth in Global Wealth and Asset Management (WAM), Asia, and Canada [3] - New business value (NBV) for the quarter was $657 million (C$906 million), up 6.3% year over year, attributed to higher sales volumes in Asia, Canada, and the U.S. division [4] Financial Performance - Wealth and asset management assets under management and administration reached $774 billion (C$1,066 billion), a 9.6% increase year over year, despite net outflows of $4.5 billion (C$6.2 billion) [5] - Core return on equity improved by 150 basis points year over year to 18.1% [5] - Adjusted book value per common share rose to $38.22, reflecting a 12% year-over-year increase [6] Segment Performance - Global WAM's core earnings were $381 million (C$525 million), up 9% year over year, driven by higher net fee income and performance fees [7] - Asia division's core earnings reached $550 million, a 29% increase year over year, supported by improved insurance experience and business growth [8] - Canada division's core earnings were $310 million (C$428 million), up 2.6% year over year, driven by higher investment spreads and business growth in group insurance [9] - The U.S. division reported core earnings of $241 million, down 20% year over year, primarily due to unfavorable life insurance claims [10] Market Outlook - Analysts have not issued any earnings estimate revisions in the last two months, indicating a stable outlook [12] - Manulife holds a Zacks Rank 2 (Buy), suggesting an expectation of above-average returns in the coming months [14] - The company is positioned within the Zacks Insurance - Life Insurance industry, which has shown positive performance, with peers like Reinsurance Group gaining 6.6% over the past month [15]

Group 1 - The core viewpoint of the news is that the Hong Kong insurance stocks have collectively risen, driven by positive market sentiment and favorable regulatory changes [1] - China Taiping increased by nearly 4%, China Life by 2.3%, and other major insurers like China Ping An and China Taibao saw gains of nearly 2% [2] - Guosheng Securities reported that the insurance industry will benefit from the trend of bank deposits moving to insurance products, with diverse demands in retirement, healthcare, and savings expected to drive industry expansion [1] Group 2 - Short-term progress in the insurance companies' performance is expected to boost the liability side for 2026, with a significant reduction in the scheduled interest rates alleviating the risk of industry spread losses [1] - UBS highlighted that the recent notification from the National Financial Regulatory Administration to adjust risk factors for insurance companies encourages long-term patient capital, which is beneficial for market sentiment [1] - UBS reiterated China Ping An as the industry’s top pick with a "buy" rating and a target price of 70 HKD, citing attractive risk-reward dynamics [1]